Gerdau SA (ADR) (GGB) Reaches $2.63 After 3.00% Down Move, Egalet (EGLT) Sentiment Is 1.89

June 20, 2017 - By Clifton Ray

Egalet Corporation is a specialty pharmaceutical company. The company has market cap of $62.63 million. The Firm is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. It currently has negative earnings. The Company’s products include OXAYDO and SPRIX Nasal Spray.

The stock of Gerdau SA (ADR) (NYSE:GGB) is a huge mover today! About 2.97 million shares traded. Gerdau SA (ADR) (NYSE:GGB) has risen 83.44% since June 20, 2016 and is uptrending. It has outperformed by 66.74% the S&P500.The move comes after 6 months negative chart setup for the $4.69 billion company. It was reported on Jun, 20 by Barchart.com. We have $2.55 PT which if reached, will make NYSE:GGB worth $140.70 million less.

Gerdau S.A. is a manufacturer of long steel in the North and South America. The company has market cap of $4.69 billion. The Firm is engaged in the production and commercialization of steel products in general, through its mills located in Argentina, Brazil, Canada, Chile, Colombia, Spain, the United States, Guatemala, India, Mexico, Peru, the Dominican Republic, Uruguay and Venezuela. It currently has negative earnings. The Company’s divisions are Brazil Operations, which includes activities of steel and iron ore in Brazil, except Special Steels, and the operation of metallurgical coal and coke in Colombia; North America Operations, which includes all activities in North America, except those of Mexico and Special Steels; South America Operations, which includes activities in South America, except Brazil and the operation of metallurgical coal and coke in Colombia, and Special Steel Operations, including special steel activities in Brazil, Spain, the United States and India.

Among 5 analysts covering Gerdau (NYSE:GGB), 3 have Buy rating, 2 Sell and 0 Hold. Therefore 60% are positive. Gerdau had 6 analyst reports since August 10, 2015 according to SRatingsIntel. The company was upgraded on Thursday, August 18 by Morgan Stanley. The firm earned “Underperform” rating on Monday, February 22 by Bank of America. The rating was upgraded by Credit Suisse on Thursday, August 4 to “Outperform”. On Tuesday, October 25 the stock rating was downgraded by Scotia Capital to “Underperform”. The rating was initiated by Goldman Sachs with “Buy” on Monday, August 10.

About 786,357 shares traded or 4.99% up from the average. Egalet Corp (EGLT) has declined 46.67% since June 20, 2016 and is downtrending. It has underperformed by 63.37% the S&P500.

Wall Street Associates holds 0.75% of its portfolio in Egalet Corp for 148,590 shares. Ecor1 Capital Llc owns 222,300 shares or 0.57% of their US portfolio. Moreover, Broadfin Capital Llc has 0.47% invested in the company for 556,233 shares. The Maryland-based Rock Springs Capital Management Lp has invested 0.15% in the stock. Wasatch Advisors Inc, a Utah-based fund reported 885,895 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: